Novartis, Pfizer Team up to develop drugs for liver disease treatment Medical Dialogues Bureau29 Oct 2018 9:30 AM ISTZURICH/NEW YORK: Novartis AG and Pfizer Inc are joining forces to develop treatments for a liver disease many drug companies believe will become a...
Eye Disease Market Primed for Shake-up: Roche touts study data of experimental Antibody Faricimab Medical Dialogues Bureau29 Oct 2018 9:00 AM ISTZURICH: Swiss drugmaker Roche has touted data for a new drug against a blindness-causing eye disease that hits millions of older people, the latest...
Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case Medical Dialogues Bureau28 Oct 2018 10:54 AM ISTNew Delhi: A Delhi court has sought a response from Sterling Biotech promoters following an Enforcement Directorate's plea to declare them fugitive...
Merck says to retain animal health business as part of company Medical Dialogues Bureau28 Oct 2018 9:05 AM ISTNew Delhi: Merck & Co Inc has recently indicated that it would keep its animal health business as part of the company, in response to questions...
Boston Scientific beats profit estimates on surgical business strength Medical Dialogues Bureau28 Oct 2018 9:00 AM ISTNew Delhi: Medical Device Boston Scientific Corp posted a slightly better-than-expected quarterly profit on Wednesday, helped by strength in its...
Sun Pharma launches psoriasis treatment drug Ilumya in US Medical Dialogues Bureau27 Oct 2018 2:09 PM ISTNew Delhi: Sun pharmaceutical has recently launched its plaque psoriasis treatment drug Ilumya in the US market. Ilumya in the strength of 100 mg/mL...
Glenmark gets USFDA approval for Fluocinolone Acetonide Topical Oil Medical Dialogues Bureau27 Oct 2018 11:36 AM ISTMumbai: Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone...
Alembic Pharma Q2 profit up 64 percent to Rs 200 crore Medical Dialogues Bureau27 Oct 2018 10:10 AM ISTNew Delhi: Alembic Pharmaceutical has reported 64.58 per cent rise in consolidated net profit to Rs 200.07 crore for the quarter ended September 30,...
Alembic Pharma gets 4 observation by USFDA for Panelav facility Medical Dialogues Bureau27 Oct 2018 10:00 AM ISTGets 4 procedural observations under Form 483New Delhi: Alembic Pharma through a recent regulatory filing announced that the United States Food and...
Why DRUG PRICES are High: CCI Policy Paper on Healthcare Medical Dialogues Bureau27 Oct 2018 10:00 AM ISTCompetition Commission of India Brings Out Policy Note on ‘Making Markets Work for Affordable Healthcare’New Delhi: The Competition Commission of...
Gilead hepatitis C drug sales fall, but profit beats estimates Medical Dialogues Bureau27 Oct 2018 9:10 AM ISTGilead, which announced in July that Chief Executive Officer John Milligan and Chairman John Martin would step down as soon as the end of the year,...
Daiichi Announces Clinical Collaboration with Merck, Pfizer Medical Dialogues Bureau27 Oct 2018 9:00 AM ISTNew Delhi: Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck KGaA, Darmstadt,...
